FORMAMIDE
General Information
Mainterm | FORMAMIDE |
CAS Reg.No.(or other ID) | 75-12-7 |
Regnum |
175.105 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 713 |
IUPAC Name | formamide |
InChI | InChI=1S/CH3NO/c2-1-3/h1H,(H2,2,3) |
InChI Key | ZHNUHDYFZUAESO-UHFFFAOYSA-N |
Canonical SMILES | C(=O)N |
Molecular Formula | CH3NO |
Wikipedia | formamide |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 45.041 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 0 |
Complexity | 12.3 |
CACTVS Substructure Key Fingerprint | A A A D c Q A C I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A F g A Q A A A A A A A A A A Y A A A B A A A A I A A A A k A A A A A A A A A A A A I A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 43.1 |
Monoisotopic Mass | 45.021 |
Exact Mass | 45.021 |
XLogP3 | None |
XLogP3-AA | -0.8 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 3 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
Food Additives Biosynthesis/Degradation
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9905 |
Human Intestinal Absorption | HIA+ | 0.9797 |
Caco-2 Permeability | Caco2+ | 0.7203 |
P-glycoprotein Substrate | Non-substrate | 0.9125 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9894 |
Non-inhibitor | 0.9913 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9304 |
Distribution | ||
Subcellular localization | Lysosome | 0.7318 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8763 |
CYP450 2D6 Substrate | Non-substrate | 0.8849 |
CYP450 3A4 Substrate | Non-substrate | 0.8022 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9287 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9422 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9671 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9694 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9721 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9480 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9811 |
Non-inhibitor | 0.9797 | |
AMES Toxicity | Non AMES toxic | 0.9439 |
Carcinogens | Carcinogens | 0.5343 |
Fish Toxicity | Low FHMT | 0.9449 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.9333 |
Honey Bee Toxicity | High HBT | 0.5899 |
Biodegradation | Ready biodegradable | 0.7551 |
Acute Oral Toxicity | IV | 0.6237 |
Carcinogenicity (Three-class) | Non-required | 0.5483 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | 1.9225 | LogS |
Caco-2 Permeability | 1.3961 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 0.9380 | LD50, mol/kg |
Fish Toxicity | 2.4824 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.5439 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic acids and derivatives |
Class | Carboximidic acids and derivatives |
Subclass | Carboximidic acids |
Intermediate Tree Nodes | Not available |
Direct Parent | Carboximidic acids |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Carboximidic acid - Organic nitrogen compound - Organic oxygen compound - Organopnictogen compound - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Imine - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as carboximidic acids. These are organic acids with the general formula RC(=N)-OH (R=H, organic group). |
From ClassyFire